SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
OEPW, LLC

(Last) (First) (Middle)
320 PARK AVENUE, 18TH FLOOR

(Street)
NEW YORK NY 10022

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
WRIGHT MEDICAL GROUP INC [ WMGI ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director X 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
12/15/2011
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
Form filed by One Reporting Person
X Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 12/15/2011 P 125,000 A $14.55(1) 5,580,549 D(4)
Common Stock 12/16/2011 P 85,200 A $14.88(2) 5,665,749 D(4)
Common Stock 12/19/2011 P 100,000 A $15.28(3) 5,765,749 D(4)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
1. Name and Address of Reporting Person*
OEPW, LLC

(Last) (First) (Middle)
320 PARK AVENUE, 18TH FLOOR

(Street)
NEW YORK NY 10022

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
One Equity Partners IV, L.P.

(Last) (First) (Middle)
320 PARK AVENUE, 18TH FLOOR

(Street)
NEW YORK NY 10022

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
OEP General Partner IV, L.P.

(Last) (First) (Middle)
320 PARK AVENUE, 18TH FLOOR

(Street)
NEW YORK NY 10022

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
OEP Parent LLC

(Last) (First) (Middle)
320 PARK AVENUE, 18TH FLOOR

(Street)
NEW YORK NY 10022

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
Explanation of Responses:
1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $14.45 to $14.64. The number of shares purchased at each separate price within the ranges set forth in footnotes (1), (2) and (3) to this Form 4 will be made available to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer upon request.
2. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $14.65 to $15.15.
3. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $15.16 to $15.55.
4. The securities are directly held by OEPW, LLC, a Delaware limited liability company ("OEPW"). The sole member of OEPW is One Equity Partners IV, L.P., a Cayman Islands limited partnership ("OEP IV"), of which the sole general partner is OEP General Partner IV, L.P., a Cayman Islands limited partnership ("OEP GP IV"), of which the sole general partner is OEP Parent LLC, a Delaware limited liability company ("OEP Parent"). The Reporting Persons are OEPW, OEP IV, OEP GP IV and OEP Parent.
OEPW, LLC, by: One Equity Partners IV, L.P., its Managing Member, By: OEP General Partner IV, L.P., its General Partner, By: OEP Parent LLC, its General Partner, /s/ Christian Ahrens, Name: Christian Ahrens, Title: Managing Director 12/19/2011
One Equity Partners IV, L.P., By: OEP General Partner IV, L.P., its General Partner, By: OEP Parent LLC, its General Partner, /s/ Christian Ahrens, Name: Christian Ahrens, Title: Managing Director 12/19/2011
OEP General Partner IV, L.P., By: OEP Parent LLC, its General Partner, /s/ Christian Ahrens, Name: Christian Ahrens, Title: Managing Director 12/19/2011
OEP Parent LLC, By: /s/ Christian Ahrens, Name: Christian Ahrens, Title: Managing Director 12/19/2011
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.